HOME >> BIOLOGY >> NEWS
New grain variety opens up possibilities for Australian farmers

Plants that are the staple food of some animals can be deadly to others. Many plants have properties that lie somewhere between the extremes of toxic and safe. Vetch is one of these.

Common vetch is useful to farmers as a versatile nitrogen-fixing crop in cereal crop rotations. The plant grows particularly well in southern Australia and has also been used as feed for cattle and other ruminants for many years, but its seeds contain about 1.1% of a known nerve toxin that is harmful to monogastric (single stomach) species such as pigs and poultry.

Now, a team of Adelaide University scientists led by Dr Max Tate at the Waite campus, has successfully produced a low toxin white-vetch grain that has offers considerable health benefits and economic possibilities.

Details of the new variety, which has the potential to improve marketing opportunities for the grain, will be released in a talk on January 31 at the 10th Australian Agronomy Conference in Hobart.

"Classic Mendelian plant breeding techniques have allowed us to reduce the toxicity of the grain by nearly two thirds, to 0.4%," Dr Tate explained. "We have used a rapid new selection procedure to produce a series of easily recognised, white seeded varieties which cannot be confused with red lentils; a completely different plant," he said.

In the past, these red lentils have caused more than a few problems. Dr Tate earned an international reputation in the 1990s when he voiced his concern at the export of a toxic Australian feed vetch as a cheap substitute for food grade lentils. According to Dr Tate, such exports to third world countries had the potential to cause serious health problems.

Exposure of the vetch/lentil substitution issue stalled the vetch grain export industry in 1993, with import bans imposed by India, Saudi Arabia and Egypt. In 1998/99 another outbreak of orange vetch exports from Australia caused Sri-Lanka, Pakistan and Bangladesh to ban their imp
'"/>

Contact: Dr Max Tate
mtate@waite.adelaide.edu.au
618-8303-7227
Adelaide University
29-Jan-2001


Page: 1 2

Related biology news :

1. Oldest evidence for processing of wild cereals: starch grains from barley, wheat, on grinding stone
2. Migraine mouse provides insight into neurobiology of devastating headaches
3. Diversity: What people, grain sorghum have in common
4. Going with the grain: A tale of rices smallest chromosome
5. Ozone may provide environmentally safe protection for grains
6. First study to show the potential for effective prevention of migraine with an AT1 receptor blocker
7. Small grain breeding program benefits producers, consumers, agribusiness
8. Herb used to treat migraine headaches could be used to develop new anti-inflammatory drugs
9. Increased consumption of whole grain foods associated with decreased risk of stroke
10. UI researchers begin to unravel the underlying mechanism of migraines
11. ORNL Finds Common Genetic Cause For Epilepsy, Migraine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 10, 2019 , ... When Dr. James L. Sherley, ... was invited to contribute a chapter to the new book Perinatal Stem Cells: Research ... Asymmetrex’s effort to address a debilitating secret of stem cell medicine. For more ...
(Date:1/7/2019)... ... 07, 2019 , ... Concerto HealthAI, a technology leader in ... oncology and other key therapeutic areas, and its Chief Executive Officer, Dr. Jeff ... spanning the entire healthcare landscape, on January 8, 2019, at 2:30 p.m. in ...
(Date:1/4/2019)... , ... January 03, 2019 , ... Stay on top ... medical device and food industries. Access to all webinars is free, so be sure ... in your field! Visit http://www.xtalks.com to check out our upcoming webinars, or ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... January 08, 2019 , ... The American Society of Gene and ... by a selection committee made up of industry leaders identified by the ASGCT board ... are mentored awards created to support ASGCT members designing transformative pilot studies in gene ...
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life , a ... blood, has been named as a partner in Medigen Biotech’s upcoming cell therapy ... for cancer treatment, will use CellMax Life’s circulating tumor cell platform CMxTM, in ...
(Date:12/19/2018)... Md. (PRWEB) , ... December 19, 2018 , ... ... for Life Science, announces the validated release of Limfinity® version 7.1. The new ... important technical offering from RURO as 2018 comes to an end. , Validation ...
(Date:12/14/2018)... ... December 14, 2018 , ... ... have been given the green light to immediately begin a clinical patient trial ... The medical devices bureau of Health Canada has granted what is called an ...
Breaking Biology Technology:
Cached News: